Home > Insider Trading > Filing (0001209191-21-021553)

Filing Details

Accession Number:: 0001209191-21-021553
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-17 19:07:29
Reporting Period:: 2021-03-16

Accepted Time:: 2021-03-17 19:07:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1679363	Morphic Holding Inc.	MORF	Pharmaceutical Preparations (2834)	473878772

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1805908	Peter Linde	C/O Morphic Holding, Inc. 35 Gatehouse Drive, A2 Waltham MA 02451	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-03-16	11,365	$0.00	12,222	No	4	M	Direct
Common Stock	Acquisiton	2021-03-16	10,378	$0.00	22,600	No	4	M	Direct
Common Stock	Disposition	2021-03-16	9,558	$63.65	13,042	No	4	S	Direct
Common Stock	Disposition	2021-03-16	1,561	$64.49	11,481	No	4	S	Direct
Common Stock	Disposition	2021-03-16	381	$65.49	11,100	No	4	S	Direct
Common Stock	Disposition	2021-03-16	500	$68.38	10,600	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit (RSU)	Disposition	2021-03-16	11,365	$0.00	11,365	$0.00
Common Stock	Restricted Stock Unit (RSU)	Disposition	2021-03-16	10,378	$0.00	10,378	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
34,095		2024-03-16	No	4	M	Direct
10,378		2021-09-16	No	4	M	Direct

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
Includes 857 shares of Common Stock acquired under the issuer's employee stock purchase plan on February 26, 2021.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.12 to $64.11 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.12 to $65.00 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.17 to $65.72 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The RSU vests 25% on each of March 16, 2021, March 16, 2022, March 16, 2023 and March 16, 2024, subject to the reporting person's provision of service to the issuer on each vesting date.
The RSU vests 50% on March 16, 2021 and the remaining 50% vests on September 16, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.